Removing Confidential Data In Clinical Trial Reports Is ‘Like Stepping On Lego’
More Than 90% Of Proposed CCI Redactions Are Public Information
An expert in transparency explained what drug sponsors can do to support their compliance staff in identifying commercially confidential information in accordance with the clinical trial transparency initiatives of Health Canada and the European Medicines Agency.
